| Autor: |
Tovt-Korshyns'ka MI, Spivak MIa, Chopei IV, Lemko IS, Kopynets' II, Il'ina VO, Kazankevych VP, Melega OO |
| Jazyk: |
ukrajinština |
| Zdroj: |
Likars'ka sprava [Lik Sprava] 2001 Jul-Aug (4), pp. 157-9. |
| Abstrakt: |
Clinical and functional efficacy of the antileukotriene agent montelucast (singulair) was investigated in 30 patients with moderately severe bronchial asthma. Patients with a positive FEV1 response to montelukast (61.1%) demonstrated a higher blood level of IgE and sputum eosinophilia. Enhancement of bronchodilatatory effect secondary to the use of beta 2-agonist has been recordable in the wake of a 24-day montelucast treatment (10 mg o.d.). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
